Adrenaline enhances LPS-induced IL-10 synthesis: Evidence for protein kinase A-mediated pathway

International Journal of Immunopharmacology

Volumn 20, Issue 1-3, 1998, Pages 57-69

  Siegmund, Britta ^a   Eigler, Andreas ^a   Hartmann, Gunther ^a   Hacker, Ulrich ^a   Endres, Stefan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adrenaline; CAMP; Interleukin 10; Tumour necrosis factor

Indexed keywords

ADRENALIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ADRENALIN RELEASE; ADRENERGIC STIMULATION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADRENERGIC AGONISTS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; EPINEPHRINE; HUMANS; INTERLEUKIN-10; KINETICS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; STIMULATION, CHEMICAL; THIONUCLEOTIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031847241     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00014-9     Document Type: Article

References (37)

1. Abrass C. K., O'Connor S. W., Scarpace P. J., Abrass I. B. J. Immunol. 135:1985;1338-1341.
2. Beutler B., Munford R. S. N. Engl. J. Med. 335:1996;348-348.
3. Bogdan C., Vodovotz Y., Nathan C. J. Exp. Med. 174:1991;1549-1555.
4. Böyum A. Scand. J. Clin. Lab. Invest. 89:1968;107-109.
5. Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J.E. J. Exp. Med. 174:1991;1209-1220.
6. Dinarello C. A., Gelfand J. A., Wolff S. M. JAMA. 269:1993;1829-1835.
7. Dostmann W. R. G. FEBS Lett. 375:1995;231-234.
8. Eigler A., Endres S. Immunol. 18:1997;487-492.
9. Eigler, A., Siegmund, B., Emmerich, U., Baumann, K. H., Hartmann, G. & Endres, S. (1998) Anti-inflammatory activities of cAMP-elevating agents: Enhancement of interleukin-10 synthesis and concurrent suppression of tumour necrosis factor production. J. of Leukocyte Biology, in press.
10. Endres S., Ghorbani R., Lonnemann G., van der Meer J. W. M., Dinarello C. A. Clin. Immunol. Immunopathol. 49:1988;424-438.
11. Fekade D., Knox K., Hussein K., Melka A., Lalloo D. G., Coxon R. E., Warrell D. A. N. Engl. J. Med. 335:1996;311-315.
12. Fiorentino D. F., Bond M. W., Mosmann T. R. J. Exp. Med. 170:1989;2081-2095.
13. Hetier E., Ayala J., Bousseau A., Prochiantz A. Exp. Brain Res. 86:1991;407-413.
14. Howard M., Muchamuel T., Andrade S., Menon S. J. Exp. Med. 177:1993;1205-1208.
15. Hsu D.-H., Moore K. W., Spits H. Int. Immunol. 4:1992;563.
16. Hu X. X., Goldmuntz E. A., Brosnan C. F. J. Neuroimmunol. 31:1991;35-42.
17. Ishizaka T., De B. R., Tomioka H., Lichtenstein L. M., Ishizaka K. J. Immunol. 108:1972;1000-1008.
18. Kambayashi T., Jacob C. O., Zhou D., Mazurek N., Fong M., Strassmann G. J. Immunol. 155:1995;4909-4916.
19. Kaminski W. E., Jendraschek E., Kiefl R., von Schacky C. Blood. 81:1993;1871-1879.
20. Khan M. M., Sansoni P., Silverman E. D., Engleman E. G., Melmon K. L. Biochem. Pharmacol. 35:1986;1137-1142.
21. Molinoff P. B. Drugs. 2:1984;1-15.
22. Monastra G., Secchi E. F. Immunol. Lett. 38:1993;127-130.
23. Nedwin G. E., Naylor S. L., Sakaguchi A. Y., Smith D., Jarrett N. J., Pennica D., Goeddel D. V., Gray P. W. Nucleic Acids Res. 13:1985;6361-6373.
24. Oswald I. P., Wynn T. A., Sher A., James S. L. Proc. Natl. Acad. Sci. 89:1992;8676.
25. Platzer C., Meisel C., Vogt K., Volk H.-D. IL-. 7:1995;517-523.
26. Ponte P., Ng S. Y., Engel J., Gunning P., Kedes L. Nucleic Acids Res. 12:1984;1687-1696.
27. Semmler J., Wachtel H., Endres S. Immunopharmacol. 409:1993;413.
28. Severn A., Rapson N. T., Hunter C. A., Liew F. Y. J. Immunol. 148:1992;3441-3445.
29. Siegmund B., Eigler A., Greten T. F., Hartmann G., Endres S. Eur. J. Pharmacol. 321:1997;231-239.
30. Sinha B., Semmler J., Eisenhut T., Eigler A., Endres S. Eur. J. Immunol. 25:1995;147-153.
31. Spengler R. N., Allen R. M., Remick D. G., Strieter R. M., Kunkel S. L. J. Immunol. 145:1990;1430-1434.
32. Taffet S. M., Singhel K. J., Overholtzer J. F., Shurtleff S. A. Immunol. 120:1989;291-300.
33. Tannenbaum C. S., Major J. A., Hamilton T. A. J. Immunol. 151:1993;6833-6839.
34. Trendelenburg, U. & Weiner, N. (1988) Catecholamines II Handbook of Experimental Pharmacology 90\II, 211-275.
35. Meer J. W. M., Endres S., Lonnemann G., Cannon J. G., Ikejima T., Okusawa S., Gelfand J. A., Dinarello C. A. J. Leukocyte Biol. 43:1988;216-223.
36. Van der Poll T., Coyle S. M., Barbosa K., Braxton C. C., Lowry S. F. J. Clin. Invest. 97:1996;713-719.
37. Vieira P., de Waal Malefyt R., Dang M.-N., Johnson K. E., Kastelein R., Fiorentino D. F., de Vries J. E., Roncarolo M.-G., Mosman T. R., Moore K. W. Proc. Natl. Acad. Sci. USA. 88:1991;1172-1176.